Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|October 15, 2011
Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusionBert Schepens, Lorena Itatí Ibañez, Sarah De Baets, et al.
Cell Death & Disease|March 30, 2022
Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategiesTeodora Oltean, Lorena Itati Ibanez, Tatyana Divert, et al.
Viruses|August 17, 2018
Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA ImmunizationAnnelies Leemans, Marlies Boeren, Winke Van der Gucht, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responsesJuan J Rojas, Lien Van Hoecke, Miquel Conesa, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Structure-based Design of Chimeric Influenza Hemagglutinins to Elicit Cross-group ImmunityKarla M Castro, Reyhaneh Ayardulabi, Sarah Wehrle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2012
The Sin3a repressor complex is a master regulator of STAT transcriptional activityLaura Icardi, Raffaele Mori, Viola Gesellchen, et al.
Mbio|December 20, 2023
A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion proteinMarlies Ballegeer, Revina C van Scherpenzeel, Teresa Delgado, et al.
EMBO Molecular Medicine|October 10, 2014
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic proteinBert Schepens, Koen Sedeyn, Liesbeth Vande Ginste, et al.
Microbial Genomics|September 3, 2021
Whole-genome-based phylogenomic analysis of the Belgian 2016-2017 influenza A(H3N2) outbreak season allows improved surveillanceLaura A E Van Poelvoorde, Bert Bogaerts, Qiang Fu, et al.
Nature Communications|December 6, 2025
Impact of pre-existing anti-replicase immunity on the efficacy of self-amplifying mRNA vaccinesXiaole Cui, Laura Amelinck, Oriane Gillon, et al.
Pageof 18